Essential drugs for anemia treatment will be produced in Ufa for the first time

Arina Rakhimkulova

UFA, 31 March 2015. /Bashinform News Agency, Arina Rakhimkulova/. Ufa branch research and production association "Microgen" "Immunopreparat" made a trial series of "Epoetin Beta" preparation for treatment of anemia. Specialists of the pharmaceutical company began to introduce the technology of its production in January 2015. Filling of the tested new product in individual sterile syringes in the amount of 6.5 thousand doses took place in the finishing department.

Now a trial series of the drug is being tested in terms of sterility, toxicity, bacterial endotoxins, and physico-chemical parametres. Industrial production of new medicine will begin in April of this year. By the end of the year it is planned to produce 100 thousand doses that will be 10 percent of the market of erythropoietin in Russia.

The "Epoetin Beta" is included in the list of vital and essential drugs for medical use in 2015.

At the moment in the Russian Federation seven trade names of erythropoietin (alpha and beta) in the form of syringes and syringe tubes 2000 IU are registered and operates, among which there are three Russian producers. The total market is over 1 million doses.

#pharmaceuticals #epoetin #production

Join us - get more news faster on our social media:

Rubrics

Phone

Office: +7(347) 250-05-07 Advertising office: +7(347) 250-11-11 Editors office: +7(347) 250-07-28 Cooperation: +7(347) 250-06-14

inf@bashinform.ru

Address

450077, Ufa, Kirov street, 45

© 1992-2026 Bashinform News Agency JSC. Mass Media Registration Certificate No. TU 02-01609 dated September 25, 2017, issued by the Office of the Federal Service for Supervision of Communications, Information Technology and Mass Media for the Republic of Bashkortostan.

All information and content posted on the website www.bashinform.ru are protected by international and Russian copyright and related rights legislation. All reports by the Bashinform News Agency are intended for users over 18 years of age.

When reprinting or quoting, a reference to Bashinform News Agency is mandatory. For online publications and social media, a direct active hyperlink is required. Using the Bashinform News Agency logo for purposes not related to the agency when reprinting or quoting is permitted only with the written permission of JSC Bashinform News Agency.